435 related articles for article (PubMed ID: 16436104)
1. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update.
Haaz S; Fontaine KR; Cutter G; Limdi N; Perumean-Chaney S; Allison DB
Obes Rev; 2006 Feb; 7(1):79-88. PubMed ID: 16436104
[TBL] [Abstract][Full Text] [Related]
2. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
[TBL] [Abstract][Full Text] [Related]
3. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain?
Allison DB; Cutter G; Poehlman ET; Moore DR; Barnes S
Int J Obes (Lond); 2005 Apr; 29(4):443-6. PubMed ID: 15700046
[TBL] [Abstract][Full Text] [Related]
4. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.
Preuss HG; DiFerdinando D; Bagchi M; Bagchi D
J Med; 2002; 33(1-4):247-64. PubMed ID: 12939122
[TBL] [Abstract][Full Text] [Related]
5. Consumption of dietary supplements containing Citrus aurantium (bitter orange)--2004 California Behavioral Risk Factor Surveillance Survey (BRFSS).
Klontz KC; Timbo BB; Street D
Ann Pharmacother; 2006 Oct; 40(10):1747-51. PubMed ID: 16968826
[TBL] [Abstract][Full Text] [Related]
6. Chromatographic and electrophoretic methods for the analysis of phenethylamine [corrected] alkaloids in Citrus aurantium.
Pellati F; Benvenuti S
J Chromatogr A; 2007 Aug; 1161(1-2):71-88. PubMed ID: 17582424
[TBL] [Abstract][Full Text] [Related]
7. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research.
Fugh-Berman A; Myers A
Exp Biol Med (Maywood); 2004 Sep; 229(8):698-704. PubMed ID: 15337824
[TBL] [Abstract][Full Text] [Related]
8. Synephrine: from trace concentrations to massive consumption in weight-loss.
Rossato LG; Costa VM; Limberger RP; Bastos Mde L; Remião F
Food Chem Toxicol; 2011 Jan; 49(1):8-16. PubMed ID: 21075161
[TBL] [Abstract][Full Text] [Related]
9. Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice.
Arbo MD; Schmitt GC; Limberger MF; Charão MF; Moro AM; Ribeiro GL; Dallegrave E; Garcia SC; Leal MB; Limberger RP
Regul Toxicol Pharmacol; 2009 Jul; 54(2):114-7. PubMed ID: 19275924
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine.
Arbo MD; Larentis ER; Linck VM; Aboy AL; Pimentel AL; Henriques AT; Dallegrave E; Garcia SC; Leal MB; Limberger RP
Food Chem Toxicol; 2008 Aug; 46(8):2770-5. PubMed ID: 18571300
[TBL] [Abstract][Full Text] [Related]
11. Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats.
Arbo MD; Franco MT; Larentis ER; Garcia SC; Sebben VC; Leal MB; Dallegrave E; Limberger RP
Arch Toxicol; 2009 Jan; 83(1):95-9. PubMed ID: 18651134
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium).
Nelson BC; Putzbach K; Sharpless KE; Sander LC
J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980
[TBL] [Abstract][Full Text] [Related]
13. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
Nykamp DL; Fackih MN; Compton AL
Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of citrus aurantium for weight loss.
Bent S; Padula A; Neuhaus J
Am J Cardiol; 2004 Nov; 94(10):1359-61. PubMed ID: 15541270
[TBL] [Abstract][Full Text] [Related]
15. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
Stohs SJ
Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
[TBL] [Abstract][Full Text] [Related]
16. Effects of Citrus aurantium (bitter orange) fruit extracts and p-synephrine on metabolic fluxes in the rat liver.
Peixoto JS; Comar JF; Moreira CT; Soares AA; de Oliveira AL; Bracht A; Peralta RM
Molecules; 2012 May; 17(5):5854-69. PubMed ID: 22592089
[TBL] [Abstract][Full Text] [Related]
17. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
[TBL] [Abstract][Full Text] [Related]
18. Availability of weight-loss supplements: Results of an audit of retail outlets in a southeastern city.
Sharpe PA; Granner ML; Conway JM; Ainsworth BE; Dobre M
J Am Diet Assoc; 2006 Dec; 106(12):2045-51. PubMed ID: 17126636
[TBL] [Abstract][Full Text] [Related]
19. A rapid and simple procedure for the determination of synephrine in dietary supplements by gas chromatography-mass spectrometry.
Marchei E; Pichini S; Pacifici R; Pellegrini M; Zuccaro P
J Pharm Biomed Anal; 2006 Jun; 41(4):1468-72. PubMed ID: 16698212
[TBL] [Abstract][Full Text] [Related]
20. Fast high-performance liquid chromatography analysis of phenethylamine alkaloids in Citrus natural products on a pentafluorophenylpropyl stationary phase.
Pellati F; Benvenuti S
J Chromatogr A; 2007 Sep; 1165(1-2):58-66. PubMed ID: 17675045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
